A B S T R A C T Platelets adhere to the subendothelial layer of newly deendothelialized arteries. Attachment can be reduced with exogenous prostacyclin (PGI2). Thus, the subendothelium may be unable to produce sufficient PGI2 to prevent platelet adherence and subsequent platelet-platelet interaction. Consistent with this explanation are data from an earlier report (1977. Moncada S., A. G. Herman, E. A. Higgs, and J. R.
Vane. Thromb. Res. 11:323-344) indicating that the smooth muscle layer of aorta has only 10-15% of the capacity of endothelial cells to synthesize PGI2. We have measured the concentrations of PGI2 synthase and prostaglandin endoperoxide (PGH) synthase in bovine aorta and obtained results quite different from those described in this earlier report. Tandem immunoradiometric assays for PGI2 synthase and PGH synthase antigens were used to quantitate these proteins in detergent-solubilized homogenates of endothelial cells and smooth muscle tissue prepared from 10 different bovine aorta. The concentrations of PGI2 synthase in endothelial cells and smooth muscle were found to be the same. However, the concentration of PGH synthase in endothelial cells averaged >20 times that of smooth muscle. Results similar to those determined by immunoradiometric assay were also obtained when PGH synthase and PGI2 synthase catalytic activities were measured in preparations of endothelial and smooth muscle cells. Furthermore, when bovine aorta and renal arteries were subjected to immunocytofluorescence staining using monoclonal antibodies to PGI2 synthase, INTRODUCTION Prostaglandin I2 (prostacyclin, PGI2)1 is a potent vasodilator and antithrombogenic agent (1) (2) (3) formed from the prostaglandin endoperoxide PGH2 through the action of prostacyclin synthase (4) (5) (6) . Early studies on rabbit aorta indicated that the endothelium was the major site of vascular PGI2 synthesis and that smooth muscle had considerably less prostacyclin synthase activity than endothelial cells (7) . These results formed the basis for the hypothesis that adherence of platelets to the vascular subendothelium resulted from a relative inability of vascular smooth muscle to synthesize I Abbreviations used in this paper: BAE cells, bovine aortic endothelial cells; DMEM, Dulbecco's-modified Eagle's medium; IRA, immunoradiometric assay; PGH synthase, prostaglandin endoperoxide synthase; PGI2 synthase, prostaglandin I2 (prostacyclin) synthase.
PGI2 from PGH2 (2, 7) . It is now clear, however, that arterial smooth muscle cells (8) (9) (10) (11) cultured from a variety of sources are capable of synthesizing PGI2 from PGH2 at rates comparable to those obtained with cultured endothelial cells (10, 11) .
We recently prepared monoclonal antibodies to PGI2 synthase (6) . In using these reagents to determine the subcellular location of this enzyme by immunocytochemistry (12), we noted that the intensity of PGI2 synthase-positive immunofluorescence was similar in both the endothelial cells and the underlying smooth muscle. This observation, coupled with previous evidence for efficient PGI2 synthesis by cultured smooth muscle cells (8) (9) (10) (11) , led us to quantitate PGI2 synthase in fresh vascular smooth muscle and endothelial cell extracts using a newly developed immunoradiometric assay (IRA) for this protein. In contrast to the results obtained by Moncada et al. (7) , our data indicate that the concentration of PGI2 synthase is the same in different layers of the vasculature; however, the results of parallel studies quantitating PGH synthase indicate that this enzyme is present in considerably higher concentrations in endothelial cells than in smooth muscle. Isolation of endothelial cells. Endothelial cells were isolated from bovine abdominal aorta using a procedure similar to the one described by Macarak et al. (13) bovine serum was used to dislodge the cells. Aliquots (0.5 ml) of the cell suspension were then applied to sterile glass coverslips placed in 100 X 20-mm culture dishes (Corning Glass Works, Corning Medical and Scientific, Corning, NY) and cells allowed to adhere overnight at 370C under a H20-saturated 10% CO2 atmosphere. The coverslips were then washed once with Krebs buffer, pH 7.4, quick-frozen in pentane (-70'C) and dried. The cells were then subjected to indirect immunocytofluorescence staining for Factor VIII antigen (14) and examined under a Leitz Orthoplan fluorescence microscope (E. Leitz, Inc., Rockleigh, NJ). In examining cells from three separate isolates, we found that >99% of the cells examined in random fields stained for Factor VIII. This indicates that our BAE cell isolates were essentially pure endothelial cell populations.
METHODS
Preparation of solubilized endothelial cell homogenates. For assays of PGH synthase, BAE cells (<100 mg wet wt) isolated from single aorta were thawed and then homogenized using a glass homogenizer in 0.5 ml of 0.1 M Trischloride, pH 8.0 containing 2.5 mM diethyldithiocarbamate, 5 mM EDTA, and 1% Tween 20. The sample was allowed to stand at 40C for 30 min. The solubilized BAE cell homogenate was used to assay (a) PGH synthase antigen by IRA or (b) cyclooxygenase activity using the radioisotope assay described below.
For assays of PGI2 synthase, the isolated BAE cells were homogenized and solubilized in 0.5 ml of 0.1 M Tris-chloride containing 10' M Flurbiprofen and 0.5% Triton X-100. This sample was used for both IRA and the enzyme activity assay.
Preparation of solubilized smooth muscle homogenates. After removal of the endothelium, the smooth muscle was cut into 2-cm8 pieces and stored at -80'C. Before assay, tissue (5 g) was cut into slivers and homogenized in 5 vol of either (a) 0.1 M Tris-chloride, pH 8.0 containing 2.5 mM diethyldithiocarbamate and 5 mM EDTA (PGH synthase) or (b) 0.1 M Tris-chloride, pH 8.0 containing 10' M Flurbiprofen (PGI2 synthase) using a homogenizer (Polytron, Brinkmann Instruments, Inc., Westbury, NY). The crude homogenate was filtered through one layer of cheesecloth. The fibrous matter that did not pass through the cheesecloth was resuspended in 5 vol of homogenizing buffer, rehomogenized, and refiltered as before. The two filtrates were combined and poured through eight layers of cheesecloth. After filtration, the cheesecloth was rinsed with 2-3 vol of homogenizing buffer, and 65 ml of this filtrate was centrifuged at 125,000 g for 60 min. The pellet was homogenized using a ground glass homogenizer in 6 ml of either (a) 0.1 M Tris-chloride, pH 8.0 containing 2 mM diethyldithiocarbamate, 5 mM EDTA, and 2% Tween 20 (for assays of PGH synthase) or (b) 0.1 M Tris-chloride buffer (pH 8.0) containing 10' Flurbiprofen and 0.5% Triton X-100 (for assays of PGI2 synthase).
IRA for PGH and PGI2 synthases. IRA for PGH synthase antigen in solubilized homogenates of BAE cells and bovine aortic smooth muscle tissue were performed as described in detail previously (15, 16) . Briefly, aliquots of solubilized tissue homogenates were added to samples containing IgG2b (cyo-5)-Staphylococcus aureus complexes to immobilize PGH synthase. "25I-Labeled IgGi (cyo-3) was then added to the immobilized enzyme-antibody complex. Following a brief incubation the sample was centrifuged at 1,000 g for 5 min and the amount of "2I label present in the resulting precipitate was measured using a Beckman Biogamma counter (Beckman Instruments, Inc., Fullerton, CA). Standard curves were generated using PGH synthase (cyclooxygenase) purified from sheep vesicular glands (17) . The purified enzyme standard had a specific activity of 45,000 cyclooxygenase units per mg of protein at 370C when assayed using a YSI model 53 oxygen monitor (17) . The results of the IRA are reported in units of cyclooxygenase activity. 1 unit is defined as the amount of activity that will catalyze formation of 1 nmol of prostaglandin/min at 370C in an assay mixture, which consists of 3.0 ml of 0.1 M Tris-chloride, pH 8.0 containing 1 mM phenol, 100 gM arachidonic acid, and 0.5 MM bovine hemoglobin.
The IRA for PGI2 synthase were performed as described previously (18) . The general procedure is similar to the IRA for PGH synthase. Solubilized microsomes from bovine aorta were used to generate a standard curve for PGI2 synthase and the results of the IRA are reported in units of PGI2 synthase activity. 1 unit is that amount of enzyme that will catalyze the formation of 1 nmol of PGI2/min at 240C in an assay mixture that consists of 0.1 ml of 0.1 M Tris-chloride, pH 8.0, containing 0.5% Triton X-100 and 50 gM
[3H]PGH2 (6).
Cyclooxygenase assays. Aliquots (10-100 Al) of solubilized BAE cells or bovine aortic smooth muscle tissue were added to 1 ml of 0.1 M Tris-chloride, pH 8.0 containing 10 MtM [3H]arachidonic acid (2 X 107 dpm/,umol), 0.5 AM bovine hemoglobin, and 1 mM phenol (17, 19) . Reactions were allowed to proceed for 1 min at 240C and were stopped by the addition of 7 ml of CHC13/methanol (1:1, vol/vol) and then extracted as described previously (19 Immunocytofluorescence. Indirect immunocytofluorescence staining of bovine aorta and bovine kidney was performed using a procedure similar to that detailed earlier (12, 22) . Briefly, blocks of fresh tissue were quick-frozen in pentane (-70°C) and sectioned on a cryotome at -25°C. The tissue sections were transferred to coverslips, dried for 30 min, and then overlayed with a first antibody preparation; these included culture media from the growth of mouse hybridoma lines cyo-1, cyo-3, or cyo-5 (all anti-PGH synthase [15] ), isn-1 or isn-3 (both anti-PGI2 synthase [6] ) or day-i (nonimmune control). After a 30-min incubation with first antibody, the sections were washed with phosphate-buffered saline, pH 7.2, and overlayed with a 1:20 dilution of fluorescein isothiocyanate-labeled rabbit anti-mouse IgG and incubated an additional 30 min. Samples were then washed, mounted on glass slides in glycerol and examined using a Leitz Orthoplan fluorescence microscope. Fluorescence microscopy was performed using an Orthomat camera and Kodak TX-135 film (Eastman Kodak Co., Rochester, NY). The photomicrographs shown in Fig. 1 were taken with identical exposure times (1 min) and the prints were developed under identical conditions so that semiquantitative comparisons of relative staining intensities can be made.
RESULTS
The levels of PGH synthase and PGI2 synthase in freshly isolated endothelial cells and smooth muscle tissue from bovine aorta were first determined using IRA for these proteins (16, 18) . The results of studies performed using tissue samples from 11 different animals are presented in Table I IRA for PGH synthase and PGI2 synthase were performed as described in the text. 1 unit of PGH synthase represents the amount of enzyme that will catalyze the formation of 1 nmol of PGH2 (from arachidonic acid) per min at 370C under the standard assay conditions. 1 unit of PGI2 synthase represents the amount of enzyme that will catalyze the formation of 1 nmol of PGI2 (from PGH2)/min at 240C under the standard assay conditions. by the early studies of Moncada et al. (7) on rabbit aorta. To examine this question, we stained cross-sections of arteries (both abdominal aorta and renal arteries) for PGH synthase and PGI2 synthase immunoreactivities using an indirect immunocytofluorescence procedure (12, 22) . As shown in Fig. 1 A for the case of bovine renal arteries, the intensity of fluorescent staining for PGI2 synthase was the same throughout the smooth muscle layer; moreover, as expected. from our quantitative IRA, the intensities of PGI2-positive fluorescence were similar in smooth muscle and endothelium. In contrast, PGH synthase immunofluorescence was considerably more intense in the endothelium than in the smooth muscle (Fig. 1 B) . Results similar to those noted in renal arteries were observed in examining sections of abdominal aorta by immunocytofluorescence. It should also be noted that the patterns of fluorescent staining shown for PGI2 synthase and PGH synthase in bovine vasculature were observed in the arterial vasculatures of rabbit, guinea pig, rat, and sheep. These latter observations suggest that the quantitative data obtained for bovine aorta (Tables I-III) 
DISCUSSION
Platelets do not adhere to the endothelium lining healthy arteries but do adhere to the subendothelium following vascular injury (24) (25) (26) . Although the binding of platelets to normal endothelial cells is not influenced by prostacyclin (24) , PGI2 may be important physiologically as an inhibitor of platelet-platelet interactions and, perhaps, as a modulator of the interactions of platelets with the subendotheliumr. Exogenous PGI2 can partially inhibit the binding of platelets to newly exposed areas of the subendothelium (1, 3, 27, 28) . There is, however, conflicting data concerning whether inhibition, of vascular PGI2 production by nonsteroidal antiinflammatory agents enhances platelet adherence to newly deendothelialized areas of arterial walls (29) (30) (31) (32) . Nevertheless, after a damaged artery begins to repair itself, there is an increase in the capacity bf the deendothelialized vessel to form PGI2 from arachidonic acid that correlates with the formation of a nonthrombogenic neointimal surface (26) . Thus, at least in the case of arteries undergoing repair, PGI2 may influence the propagation of platelet aggregates and perhaps to a lesser extent the initial adhesion of platelets to subintimal structures.
The propensity of platelets to adhere to the subendothelium of newly damaged vessels has been attributed to the relative inability of this cell layer to synthesize PGI2 (2, 33 (26) .
The functional significance of the difference in PGH synthase concentrations between smooth muscle and endothelium is not obvious. We propose the following speculative scenario. In general, the amount of prostaglandin end-product released in response to a cellular stimulus is determined by the efficiency with which arachidonate liberated from precursor lipids is converted to PGH2 (23, 34) . Therefore, for two different cells containing the same level of PGI2 synthase, the concentration of PGH synthase is likely to be an indicator of the relative ability of each cell to synthesize and release PGI2. Both the endothelium of healthy arteries and the neointima of damaged arteries (26) have relatively high levels of PGH synthase activity. We speculate that as a consequence the lining of arteries usually maintains a high capacity to release PGI2 into the vascular lumen, where PGI2 presumably can influence platelet function. Conversely, smooth muscle, which has relatively low PGH synthase activity, probably makes less PGI2 in response to cellular stimuli and the PGI2 synthesized may function principally, if not exclusively, within the smooth muscle layer to regulate vascular tone. Consistent with this narrow role proposed for PGI2 originating in vascular smooth muscle are the findings (a) that all smooth muscle, both vatscular and nonvascular, forms PGI2 and (b) that the ratios of PGI2 synthase to PGH synthase appear to be similarly high in all smooth muscle (12) .
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